Second Genome Digests Series A
San Francisco-based Second Genome, a firm developing microbial-based, personalized medicine products for the gastrointestinal disease area, said yesterday that it has raised $5M in a funding round. The round was co-led by Advanced Technology Ventures and Morgenthaler Ventures, and included Wavepoint Ventures, Seraph Group, as well as others. The firm said the funding will go towards further development of its microbiome‐based personalized medicine solutions for gastrointestinal diseases and disorders. The firm is headed by Peter DiLaura.
posted on Wednesday, August 10, 2011 (Link to more information)
Related companies:
Second Act Partners
Related stories:
> Genome Medical Gains $23M
> Twist Bioscience Buys Genome Compiler
> Personalis Raises $22M For Genome Sequencing
> Synthego Gets $41M For Genome Engineering
> Second Genome Scoops Up $42.6M
silicontap.com Home